Wound Healing & Scar Reduction Dosage: 25 mg per day (SC injection) or topical application Cycle: 46 weeks, repeated as needed Administration: Injectable: Post-surgery or post-injury Topical: Apply directly to wounds or scars twice daily Stacking: With BPC-157 for accelerated tissue repair With TB-500 for reduced fibrosis and scar formation With GH-releasing peptides (CJC-1295 & Ipamorelin) for enhanced regenerative effects Expected Benefits: Faster wound healing and tissue recovery Reduced scar tissue and fibrosis formation Enhanced angiogenesis (new blood vessel growth) 3
Fatigue is a common complaint during the early weeks of GLP-1 treatment, particularly as calorie intake drops and the body adjusts to lower food volume
Afshin-Majd S, Bashiri K, Kiasalari Z, Baluchnejadmojarad T, Sedaghat R, et al
[17] Disclaimer: The products mentioned are not intended for human or animal consumption
Secondary mechanisms include modulation of inflammatory cytokines and interaction with growth factor receptors, contributing to its broad regenerative profile in research models focused on musculoskeletal, gastrointestinal, and neural tissues